Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing
Reexamination Certificate
2006-05-16
2006-05-16
Smith, Lynette R. F. (Department: 1645)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
C424S093200, C424S184100, C424S234100, C424S235100, C424S258100
Reexamination Certificate
active
07045122
ABSTRACT:
The present invention relates to live attenuatedSalmonellastrains comprising a first attenuating mutation, that are not capable of making functional RecA. The invention also relates to these bacteria for use in vaccines. Furthermore, the invention relates to vaccines based upon these bacteria, to the use of such bacteria in the manufacture of vaccines and to methods for the preparation of such vaccines.
REFERENCES:
patent: 0 650 733 (1995-05-01), None
patent: 97 18837 (1997-05-01), None
patent: 98 56901 (1998-12-01), None
patent: WO 98/56901 (1998-12-01), None
Thomas E. Creighton, in his book, Proteins: Structures and Molecular Properties, 1984.
Thomas E. Creighton, in his book “Protein Structure: A Practical Approach, 1989, pp. 184-186”.
Nosoh, Y. et al in “Protein Stability and Stabilization through Protein Engineering, 1991” (chapter 7, p. 197, second paragraph).
Ferguson et al, (Mutation Research, 1987, 184 13-21).
Buchmeier et al, (Molecular Microbiology, 1993, 7(6), 933-936).
Mortelmans et al Journal of Bacteriology, 128, 271-282, 1976.
Griffin et al, Vaccine, 1993, vol. 11, No. 4, p. 457-62.
Griffin, Worlds Poult. Sci.J., 1991, vol. 47, No. 2, p. 129-40.
Ferguson L R et al: “Frameshift Mutagenesis by Nitracrine Analogues in Wild-Type uvr-B pol-A and rec-A Strains ofSalmonella-typhimuriumWith and Without Plasmid p-KM-101”; Mutations Research; vol. 184, No. 1, 1987, pp. 13-21.
Johnson B N et al: “Construction ofSalmonellaStrains with Both Antigen 04 of Gropu B and Antigen 09 of Group D”; Journal of Bacteriology, vol. 174, No. 6, 1992, pp. 1911-1915.
Buchmeier Nancy A et al: “Recombination-Deficient Mutants ofSalmonella typhimuriumare Avirulent and Sensitive to the Oxidative Burst of Macrophages.”; Molecular Microbiology, vol. 7, No. 6, 1993, pp. 933-936.
Guerry, P. et al.: “Development and Characterization of recA Mutants ofCampylobacter jejunifor Inclusion in Attenuated Vaccines”; Infection and Immunity; vol. 62, No. 2, Feb. 1994.
Nuijten Petrus Johannes Maria
Witvliet Maarten Hendrik
Akzo Nobel N.V.
Ford Vanessa L.
Gryte David M.
Milstead Mark W.
Smith Lynette R. F.
LandOfFree
Salmonella vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Salmonella vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Salmonella vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3546949